Radiation Oncology/Therapy: Page 17

PET/CT reveals different reactions to COVID-19 vaccines

By Will Morton

PET/CT imaging shows that COVID-19 mRNA vaccines appear to cause higher rates of reactive lymph nodes in cancer patients compared with whole-virus vaccines, according to a study presented at the American Roentgen Ray Society meeting in Honolulu.

April 26, 2023

ASTRO, ESTRO issue guidelines for lung cancer therapy

By AuntMinnie.com staff writers

The American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO) have issued guidance on the use of definitive local therapy to treat patients with oligometastatic non-small cell lung cancer.

April 25, 2023

Is special labeling needed for radioactive specimens?

By Will Morton

Special labeling and shipping precautions for radioactive sentinel lymph node (SLN) specimens may not be necessary in hospitals, according to a study published April 21 in the Journal of Medical Imaging and Radiation Science.

April 25, 2023

Lantheus secures FDA fast track designation for prostate cancer drug

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent company Lantheus Holdings and partner Point Biopharma Global have secured fast-track designation from the U.S. Food and Drug Administration (FDA) for lutetium-177 PNT2002, a radiopharmaceutical for the treatment of metastatic, castration-resistant prostate cancer.

April 23, 2023

New MRI technique helps target ultrasound-guided prostate biopsy

By Kate Madden Yee

A new microstructure imaging technique, hybrid multidimensional MRI (HM-MRI), could enable better targeting of areas in the prostate that need to be biopsied, according to a presentation at the American Roentgen Ray Society annual meeting in Honolulu.

April 23, 2023

Viewray posts 2023 Q1 revenue increases

By AuntMinnie.com staff writers

Viewray posted revenue increases in its first quarter and outlined strategic business alternatives it is exploring to "maximize shareholder value."

April 12, 2023

FDA clears Fusion's targeted alpha therapy

By AuntMinnie.com staff writers

Fusion Pharmaceuticals has secured clearance from the U.S. Food and Drug Administration (FDA) for its radiopharmaceuticals actinium-225-FPI-2068 and corresponding imaging analog Indium-111-FPI-2107.

April 12, 2023

How effective is micro-CT for assessing breast tumor margins?

By Kate Madden Yee

Micro-CT shows promise as an additional tool to standard-of-care assessment of tumor margins during breast-conserving surgery, according to a study published April 11 in the Annals of Surgical Oncology.

April 12, 2023

ImaginAB licenses immuno-PET tracer to Leucid

By AuntMinnie.com staff writers

Immuno-PET developer ImaginAB has licensed its zirconium-89 crefmirlimab berdoxam radiotracer to biotech company Leucid for use in studies of solid tumors.

April 11, 2023

China authorizes Qi Kang Medical Technology to open new facility

By AuntMinnie.com staff writers

The Department of Ecology and Environment of Jiangsu Province in China has authorized Eckert & Ziegler subsidiary Qi Kang Medical Technology to construct a radioisotope production facility in Jintan.

April 11, 2023

PET/CT bests bone scintigraphy for detecting invasive breast cancer

By Will Morton

PET/CT imaging surpasses bone scintigraphy for detecting bone metastases in women with invasive breast cancer and should be the technique of choice to stage these patients, according to a team of investigators from Portugal.

April 11, 2023

ACS: COVID-19 increased deaths from cancer as contributing factor

By Kate Madden Yee

A new American Cancer Society (ACS) report has found that mortality rates with cancer as a contributing factor were higher in 2020 -- the first year of the COVID-19 pandemic -- compared with prepandemic 2019 rates.

April 10, 2023

Previous Page

Page 17 of 468

Next Page